Free Trial

Molecular Partners (MOLN) Earnings Date, Estimates & Call Transcripts

Molecular Partners logo
$4.00 -0.06 (-1.35%)
As of 05/28/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Molecular Partners Earnings Summary

Molecular Partners issued Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.50, which missed the consensus estimate of -$0.39 by $0.11. With a trailing EPS of -$1.92, Molecular Partners' earnings are expected to decrease next year, from ($1.93) to ($2.08) per share.

Q1 2025 Earnings Resources

Latest Q1
Earnings Date
May. 15Estimated
Consensus EPS
(May. 15)
-$0.39
Actual EPS
(May. 15)
-$0.50 Missed By -$0.11
Get Molecular Partners Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Molecular Partners and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MOLN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MOLN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Molecular Partners Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20251-$0.53-$0.53-$0.53
Q3 20251-$0.53-$0.53-$0.53
Q4 20251-$0.53-$0.53-$0.53

Molecular Partners Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025-$0.3855-$0.50 -$0.1145-$0.50--
3/6/2025H2 2024-$0.45-$0.34+$0.11-$0.34--
10/31/2024--$0.63-$0.57+$0.06-$0.57-$0.79M
8/26/2024H1 2024--$0.51 -$0.51-$0.51-$1.72M
5/16/2024Q1 2024--$0.39 -$0.39-$0.39-$3.13M
3/14/2024H2 2023--$0.68 -$0.68-$0.68-$1.17M
10/26/2023Q3 2023--$0.40 -$0.40-$0.40-$2.88M
8/23/2023H1 2023--$0.55 -$0.55-$0.55-$0.46M

Molecular Partners Earnings - Frequently Asked Questions

Molecular Partners (NASDAQ:MOLN) last announced its quarterly earning data on Thursday, May 15, 2025. Learn more on MOLN's earnings history.

In the previous quarter, Molecular Partners (NASDAQ:MOLN) missed the analysts' consensus estimate of ($0.39) by $0.11 with a reported earnings per share (EPS) of ($0.50). Learn more on analysts' earnings estimate vs. MOLN's actual earnings.

Molecular Partners (NASDAQ:MOLN) has a recorded annual revenue of $2.23 million.

Molecular Partners (NASDAQ:MOLN) has a recorded net income of -$69.04 million. MOLN has generated -$1.92 earnings per share over the last four quarters.

Molecular Partners's earnings are expected to decrease from ($1.93) per share to ($2.08) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:MOLN) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners